| National Health Research Institute Patent applications |
| Patent application number | Title | Published |
|---|
| 20110159518 | METHOD FOR THE DIAGNOSIS OF THE PRESENCE OF AN OVARIAN CANCER - The invention provides an isolated antigen polypeptide that can be expressed in a subject with ovarian cancer. Also provided is the diagnosis of ovarian cancer by using the antigen polypeptide of the invention and the prevention and/or treatment of ovarian cancer by suppressing the gene of the antigen polypeptide of the invention. | 06-30-2011 |
| 20100167950 | MICROARRAY CHIP AND METHOD OF FABRICATING FOR THE SAME - The present invention provides a microarray chip for use in the analysis of various sample types. The microarray chips disclosed herein generally comprise a substrate covered with a coating material comprising a photoresist material, wherein the coating material is patterned to comprise a plurality of microstructures such as microwells and/or microcolumns. Methods for preparing and utilizing the microarray chips of the invention are further provided. The microarray chips of the instant invention find particular use in high-throughput assays. | 07-01-2010 |
| 20100111956 | ANTIGEN POLYPEPTIDE FOR THE DIAGNOSIS AND/OR TREATMENT OF OVARIAN CANCER - The invention provides an isolated antigen polypeptide that can be expressed in a subject with ovarian cancer. Also provided is the diagnosis of ovarian cancer by using the antigen polypeptide of the invention and the prevention and/or treatment of ovarian cancer by suppressing the gene of the antigen polypeptide of the invention. | 05-06-2010 |
| 20090098056 | ALPK1 GENE VARIANTS IN DIAGNOSIS RISK OF GOUT - The present invention relates to a method of identifying a human subject having an elevated risk of gout and/or hyperuricemia by detecting the occurrence of at least one SNP associated with an elevated risk of gout in an ALPK1 gene in a biological sample from the subject, or by determining the expression level of an ALPK1 gene in a biological sample from the subject. Also disclosed is an isolated nucleic acid molecule, its complement or gene variant comprising at least one of the polymorphisms identified herein to be associated with gout and/or hyperuricemia, a kit for performing a diagnostic test to identify a human subject having an elevated risk of gout and/or hyperuricemia, and a method of selecting or identifying a compound useful for treating gout and/or hyperuricemia. | 04-16-2009 |
| 20090081121 | LIPOSOME COMPOSITIONS USEFUL FOR TUMOR IMAGING AND TREATMENT - The invention relates to liposome compositions for delivering, for example, therapeutic, diagnostic, and imaging agents to a subject. Methods for preparing and using such liposome compositions are further provided. The compositions and methods of the invention find particular use in treating, diagnosing, and imaging a tumor in a subject. | 03-26-2009 |
| 20090074781 | Dengue virus peptide vaccine and methods of preparing and using the same - A consensus peptide sequence designed for domain III of the envelope proteins of four serotypes of dengue virus and used in a vaccine against multiple serotypes of dengue virus is disclosed. The vaccine is able to elicit cross-neutralization antibody responses against multiple serotypes of dengue virus. | 03-19-2009 |
